The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Medical Contrast Agent Market Research Report 2024

Global Medical Contrast Agent Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1535290

No of Pages : 89

Synopsis
Contrast agents (or contrast media) is a substance used to increase the contrast of structures or fluids within the body in medical imaging. Contrast agents absorb or alter external electromagnetism or ultrasound, which is different from radiopharmaceuticals, which emit radiation themselves. Contrast media, enhance the radiodensity in a target tissue or structure.
The global Medical Contrast Agent market was valued at US$ 5387 million in 2023 and is anticipated to reach US$ 6860.8 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Medical Contrast Agent, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medical Contrast Agent.
Report Scope
The Medical Contrast Agent market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Medical Contrast Agent market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Medical Contrast Agent manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GE Healthcare
Bayer
Bracco Imaging
Guerbet Group
Lantheus Medical Imaging
Nanopet Pharma
CMC Contrast
Daiichi Sankyo
Subhra Pharma Private
Spago Nanomedical
Segment by Type
Barium-based Contrast Media
Iodinated Contrast Media
Gadolinium-based Contrast Media
Microbubble Contrast Media
Segment by Application
Cardiovascular Disorders
Neurological Disorders
Gastrointestinal Disorders
Cancer
Nephrological Disorders
Musculoskeletal Disorders
Other Applications
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Medical Contrast Agent manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Medical Contrast Agent in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Medical Contrast Agent Market Overview
1.1 Product Overview and Scope of Medical Contrast Agent
1.2 Medical Contrast Agent Segment by Type
1.2.1 Global Medical Contrast Agent Market Value Comparison by Type (2024-2030)
1.2.2 Barium-based Contrast Media
1.2.3 Iodinated Contrast Media
1.2.4 Gadolinium-based Contrast Media
1.2.5 Microbubble Contrast Media
1.3 Medical Contrast Agent Segment by Application
1.3.1 Global Medical Contrast Agent Market Value by Application: (2024-2030)
1.3.2 Cardiovascular Disorders
1.3.3 Neurological Disorders
1.3.4 Gastrointestinal Disorders
1.3.5 Cancer
1.3.6 Nephrological Disorders
1.3.7 Musculoskeletal Disorders
1.3.8 Other Applications
1.4 Global Medical Contrast Agent Market Size Estimates and Forecasts
1.4.1 Global Medical Contrast Agent Revenue 2019-2030
1.4.2 Global Medical Contrast Agent Sales 2019-2030
1.4.3 Global Medical Contrast Agent Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Medical Contrast Agent Market Competition by Manufacturers
2.1 Global Medical Contrast Agent Sales Market Share by Manufacturers (2019-2024)
2.2 Global Medical Contrast Agent Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Medical Contrast Agent Average Price by Manufacturers (2019-2024)
2.4 Global Medical Contrast Agent Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Medical Contrast Agent, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Medical Contrast Agent, Product Type & Application
2.7 Medical Contrast Agent Market Competitive Situation and Trends
2.7.1 Medical Contrast Agent Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Medical Contrast Agent Players Market Share by Revenue
2.7.3 Global Medical Contrast Agent Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Medical Contrast Agent Retrospective Market Scenario by Region
3.1 Global Medical Contrast Agent Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Medical Contrast Agent Global Medical Contrast Agent Sales by Region: 2019-2030
3.2.1 Global Medical Contrast Agent Sales by Region: 2019-2024
3.2.2 Global Medical Contrast Agent Sales by Region: 2025-2030
3.3 Global Medical Contrast Agent Global Medical Contrast Agent Revenue by Region: 2019-2030
3.3.1 Global Medical Contrast Agent Revenue by Region: 2019-2024
3.3.2 Global Medical Contrast Agent Revenue by Region: 2025-2030
3.4 North America Medical Contrast Agent Market Facts & Figures by Country
3.4.1 North America Medical Contrast Agent Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Medical Contrast Agent Sales by Country (2019-2030)
3.4.3 North America Medical Contrast Agent Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Medical Contrast Agent Market Facts & Figures by Country
3.5.1 Europe Medical Contrast Agent Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Medical Contrast Agent Sales by Country (2019-2030)
3.5.3 Europe Medical Contrast Agent Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Medical Contrast Agent Market Facts & Figures by Country
3.6.1 Asia Pacific Medical Contrast Agent Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Medical Contrast Agent Sales by Country (2019-2030)
3.6.3 Asia Pacific Medical Contrast Agent Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Medical Contrast Agent Market Facts & Figures by Country
3.7.1 Latin America Medical Contrast Agent Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Medical Contrast Agent Sales by Country (2019-2030)
3.7.3 Latin America Medical Contrast Agent Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Medical Contrast Agent Market Facts & Figures by Country
3.8.1 Middle East and Africa Medical Contrast Agent Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Medical Contrast Agent Sales by Country (2019-2030)
3.8.3 Middle East and Africa Medical Contrast Agent Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Medical Contrast Agent Sales by Type (2019-2030)
4.1.1 Global Medical Contrast Agent Sales by Type (2019-2024)
4.1.2 Global Medical Contrast Agent Sales by Type (2025-2030)
4.1.3 Global Medical Contrast Agent Sales Market Share by Type (2019-2030)
4.2 Global Medical Contrast Agent Revenue by Type (2019-2030)
4.2.1 Global Medical Contrast Agent Revenue by Type (2019-2024)
4.2.2 Global Medical Contrast Agent Revenue by Type (2025-2030)
4.2.3 Global Medical Contrast Agent Revenue Market Share by Type (2019-2030)
4.3 Global Medical Contrast Agent Price by Type (2019-2030)
5 Segment by Application
5.1 Global Medical Contrast Agent Sales by Application (2019-2030)
5.1.1 Global Medical Contrast Agent Sales by Application (2019-2024)
5.1.2 Global Medical Contrast Agent Sales by Application (2025-2030)
5.1.3 Global Medical Contrast Agent Sales Market Share by Application (2019-2030)
5.2 Global Medical Contrast Agent Revenue by Application (2019-2030)
5.2.1 Global Medical Contrast Agent Revenue by Application (2019-2024)
5.2.2 Global Medical Contrast Agent Revenue by Application (2025-2030)
5.2.3 Global Medical Contrast Agent Revenue Market Share by Application (2019-2030)
5.3 Global Medical Contrast Agent Price by Application (2019-2030)
6 Key Companies Profiled
6.1 GE Healthcare
6.1.1 GE Healthcare Corporation Information
6.1.2 GE Healthcare Description and Business Overview
6.1.3 GE Healthcare Medical Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.1.4 GE Healthcare Medical Contrast Agent Product Portfolio
6.1.5 GE Healthcare Recent Developments/Updates
6.2 Bayer
6.2.1 Bayer Corporation Information
6.2.2 Bayer Description and Business Overview
6.2.3 Bayer Medical Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Bayer Medical Contrast Agent Product Portfolio
6.2.5 Bayer Recent Developments/Updates
6.3 Bracco Imaging
6.3.1 Bracco Imaging Corporation Information
6.3.2 Bracco Imaging Description and Business Overview
6.3.3 Bracco Imaging Medical Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bracco Imaging Medical Contrast Agent Product Portfolio
6.3.5 Bracco Imaging Recent Developments/Updates
6.4 Guerbet Group
6.4.1 Guerbet Group Corporation Information
6.4.2 Guerbet Group Description and Business Overview
6.4.3 Guerbet Group Medical Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Guerbet Group Medical Contrast Agent Product Portfolio
6.4.5 Guerbet Group Recent Developments/Updates
6.5 Lantheus Medical Imaging
6.5.1 Lantheus Medical Imaging Corporation Information
6.5.2 Lantheus Medical Imaging Description and Business Overview
6.5.3 Lantheus Medical Imaging Medical Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Lantheus Medical Imaging Medical Contrast Agent Product Portfolio
6.5.5 Lantheus Medical Imaging Recent Developments/Updates
6.6 Nanopet Pharma
6.6.1 Nanopet Pharma Corporation Information
6.6.2 Nanopet Pharma Description and Business Overview
6.6.3 Nanopet Pharma Medical Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Nanopet Pharma Medical Contrast Agent Product Portfolio
6.6.5 Nanopet Pharma Recent Developments/Updates
6.7 CMC Contrast
6.6.1 CMC Contrast Corporation Information
6.6.2 CMC Contrast Description and Business Overview
6.6.3 CMC Contrast Medical Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.4.4 CMC Contrast Medical Contrast Agent Product Portfolio
6.7.5 CMC Contrast Recent Developments/Updates
6.8 Daiichi Sankyo
6.8.1 Daiichi Sankyo Corporation Information
6.8.2 Daiichi Sankyo Description and Business Overview
6.8.3 Daiichi Sankyo Medical Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Daiichi Sankyo Medical Contrast Agent Product Portfolio
6.8.5 Daiichi Sankyo Recent Developments/Updates
6.9 Subhra Pharma Private
6.9.1 Subhra Pharma Private Corporation Information
6.9.2 Subhra Pharma Private Description and Business Overview
6.9.3 Subhra Pharma Private Medical Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Subhra Pharma Private Medical Contrast Agent Product Portfolio
6.9.5 Subhra Pharma Private Recent Developments/Updates
6.10 Spago Nanomedical
6.10.1 Spago Nanomedical Corporation Information
6.10.2 Spago Nanomedical Description and Business Overview
6.10.3 Spago Nanomedical Medical Contrast Agent Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Spago Nanomedical Medical Contrast Agent Product Portfolio
6.10.5 Spago Nanomedical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Medical Contrast Agent Industry Chain Analysis
7.2 Medical Contrast Agent Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Medical Contrast Agent Production Mode & Process
7.4 Medical Contrast Agent Sales and Marketing
7.4.1 Medical Contrast Agent Sales Channels
7.4.2 Medical Contrast Agent Distributors
7.5 Medical Contrast Agent Customers
8 Medical Contrast Agent Market Dynamics
8.1 Medical Contrast Agent Industry Trends
8.2 Medical Contrast Agent Market Drivers
8.3 Medical Contrast Agent Market Challenges
8.4 Medical Contrast Agent Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’